HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting of a Fixed Bacterial Immunogen to Fc Receptors Reverses the Anti-Inflammatory Properties of the Gram-Negative Bacterium, Francisella tularensis, during the Early Stages of Infection.

Abstract
Production of pro-inflammatory cytokines by innate immune cells at the early stages of bacterial infection is important for host protection against the pathogen. Many intracellular bacteria, including Francisella tularensis, the agent of tularemia, utilize the anti-inflammatory cytokine IL-10, to evade the host immune response. It is well established that IL-10 has the ability to inhibit robust antigen presentation by dendritic cells and macrophages, thus suppressing the generation of protective immunity. The pathogenesis of F. tularensis is not fully understood, and research has failed to develop an effective vaccine to this date. In the current study, we hypothesized that F. tularensis polarizes antigen presenting cells during the early stages of infection towards an anti-inflammatory status characterized by increased synthesis of IL-10 and decreased production of IL-12p70 and TNF-α in an IFN-ɣ-dependent fashion. In addition, F. tularensis drives an alternative activation of alveolar macrophages within the first 48 hours post-infection, thus allowing the bacterium to avoid protective immunity. Furthermore, we demonstrate that targeting inactivated F. tularensis (iFt) to Fcγ receptors (FcɣRs) via intranasal immunization with mAb-iFt complexes, a proven vaccine strategy in our laboratories, reverses the anti-inflammatory effects of the bacterium on macrophages by down-regulating production of IL-10. More specifically, we observed that targeting of iFt to FcγRs enhances the classical activation of macrophages not only within the respiratory mucosa, but also systemically, at the early stages of infection. These results provide important insight for further understanding the protective immune mechanisms generated when targeting immunogens to Fc receptors.
AuthorsZulfia Babadjanova, Kari Wiedinger, Edmund J Gosselin, Constantine Bitsaktsis
JournalPloS one (PLoS One) Vol. 10 Issue 6 Pg. e0129981 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26114641 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigen-Antibody Complex
  • Antigens, Bacterial
  • Cytokines
  • Inflammation Mediators
  • Receptors, Fc
  • Receptors, IgG
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antigen-Antibody Complex (immunology)
  • Antigens, Bacterial (immunology)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Francisella tularensis (immunology)
  • Inflammation Mediators (metabolism)
  • Lung (immunology, metabolism, pathology)
  • Macrophage Activation (immunology)
  • Macrophages, Peritoneal (immunology, metabolism)
  • Mice
  • Mice, Knockout
  • Receptors, Fc (metabolism)
  • Receptors, IgG (metabolism)
  • Tularemia (immunology, metabolism, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: